about
Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causi...
Read More
3.21
0.12
(3.88%)
334.4K
XNAS Volume
XNAS 08 May, 2026 1:38 PM (EDT)
Board Meeting
The next board meeting for Rezolute Inc is on 13 May 2026 for the purpose of Rezolute Inc Third Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Bearish
Rezolute Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..